Characterization Of Haemopoietic Lineage Determining Genes
Funder
National Health and Medical Research Council
Funding Amount
$631,021.00
Summary
Haemopoiesis is the process by which blood cells develop from stem cells. This process is tightly regulated and is dependant upon the appropriate expression of genes at each developmental stage within various lineages. Our work focuses on two genes (Mlf1 and Hls5) that are involved in determining lineage commitment and affect the expression of key hemopoietic regulators. If these genes are aberrantly expressed leukemias and other blood disorders can develop.
Cell-targeted Gene Delivery Into Human Haematopoietic Stem Cells For The Treatment Of Thalassaemia
Funder
National Health and Medical Research Council
Funding Amount
$171,208.00
Summary
Thalassaemia is the most common inherited single gene disorder affecting haemoglobin synthesis in red blood cells. It mainly affects people of Mediterranean, Middle Eastern, African, South East Asian, Chinese, and Indian origin. However, large numbers of thalassaemia patients are found nowadays in Australia and other developed countries, due to large population movements in the twentieth century. Approximately 300,000 severely affected children are born each year with thalassaemia and various ot ....Thalassaemia is the most common inherited single gene disorder affecting haemoglobin synthesis in red blood cells. It mainly affects people of Mediterranean, Middle Eastern, African, South East Asian, Chinese, and Indian origin. However, large numbers of thalassaemia patients are found nowadays in Australia and other developed countries, due to large population movements in the twentieth century. Approximately 300,000 severely affected children are born each year with thalassaemia and various other abnormalities of haemoglobin synthesis. If untreated, most thalassaemia patients will die within the first few years of life. The vast majority of thalassaemia patients depend on regular blood transfusions every two to three weeks, and on nightly infusions of an iron chelator (a drug for removing excess iron from the blood). These procedures place considerable burden on thalassaemia patients, their families and society, and expose them to blood transmitted infections. The only curative treatment for thalassaemia is bone marrow transplantation from a matching donor. However, the vast majority of patients do not have matching donors and thus the only prospect for them to receive such therapy is to replace in their bone marrow cells a copy of the normal set of genes for the synthesis of haemoglobin. The studies in this proposal are therefore designed to test gene therapy protocols on bone marrow stem cells derived from thalassaemia patients. A normal set of globin genes will be delivered to the bone marrow stem cells via non-viral delivery systems and examined for function in an immunodeficient mouse strain that can accept human bone marrow. This research may enable bone marrow transplantation to be applied for the therapy of most patients with thalassaemia, while it may also have a major impact on therapeutic approaches for other haematological anomalies.Read moreRead less
Characterisation Of Novel Regulators Of The Haemopoeitic System.
Funder
National Health and Medical Research Council
Funding Amount
$381,680.00
Summary
All of the circulating blood cells (including red cells and white cells) develop from a single cell type, called the haemopoietic stem cell (HSC), found in the adult bone marrow. Normally, HSCs are gradually restricted to become only one cell type and once they have started down that pathway can no longer generate cells of another pathway (e.g. once HSC begin to develop into red blood cells, they cannot normally change their direction to become white cells). There are a few examples of mature ce ....All of the circulating blood cells (including red cells and white cells) develop from a single cell type, called the haemopoietic stem cell (HSC), found in the adult bone marrow. Normally, HSCs are gradually restricted to become only one cell type and once they have started down that pathway can no longer generate cells of another pathway (e.g. once HSC begin to develop into red blood cells, they cannot normally change their direction to become white cells). There are a few examples of mature cells, however, that have changed pathways. We have use one of these, the mouse J2E red cell changing into macrophages, to identify the genes involved in this process. Two of the genes we found, HLS5 and HLS7, are potentially important in lineage determination and normal blood development as well as the formation of blood cancers. This project aims to investigate the roles these genes play in blood development. Much of our work to date has focused on HLS7. The human equivalent of HLS7 was found by an American group independently of us as a gene which causes one type of blood cancer. We have shown HLS7 has dramatic effects on normal blood development and, together, these results clearly show the importance of this gene. Through our studies on how HLS7 works, we have identified another gene, M44, which may be important in regulation of HLS7 and also plan to investigate is function. Finally, HLS5 has similarities to a group of molecules called transcription factors which are known to be key regulators blood development. Clearly, analysis of this gene will further our knowledge in this field.Read moreRead less
Haemopoiesis is the process by which cells in the blood become committed to a specific cell type, mature and proliferate. The production of blood cells is a dynamic and constant process and if dysregulated will result in a number of different diseases and-or leukemias. Using a leukemic cell line we identified two genes, Hls5 and Hls7-Mlf1, involved in red blood cell maturation. In addition, both these genes have been implicated in cancer, Hls5 functions as a tumor suppressor and Mlf1 is associat ....Haemopoiesis is the process by which cells in the blood become committed to a specific cell type, mature and proliferate. The production of blood cells is a dynamic and constant process and if dysregulated will result in a number of different diseases and-or leukemias. Using a leukemic cell line we identified two genes, Hls5 and Hls7-Mlf1, involved in red blood cell maturation. In addition, both these genes have been implicated in cancer, Hls5 functions as a tumor suppressor and Mlf1 is associated with acute myeloid leukemia. Over-expression of either gene in immature red blood cells inhibited their development; Mlf1 had quite a profound affect on cell shape and size whereas Hls5 affected biochemical pathways with a decrease in haemoglobin production. We have identified binding partners of each of the molecules. Hls5 binds to FOG 1, a regulator of the red blood cell genes. In addition, Hls5 associates with Ubc9 and PIAS-1 - molecules involved in a novel form of gene regulation called sumoylation. Hls5 also regulates GATA-1 a key protein in red cell production. Wer have recently found that Mlf1 also regulates GATA-1. Importantly, we have demonstrated that Mlf1 binds DNA and other nuclear proteins and is able to affect gene transcription. This project will use cellular and biochemical assays as well as mouse models to elucidate the mechanisms by which these genes control the function of red blood cells.Read moreRead less
Understanding uterine contractility for reducing newborn lamb mortality. The project aims to elucidate the mechanisms underlying normal and dysfunctional uterine contractions in labouring ewes. Significantly, ~20% of newborn lambs die within days of birth, costing the Australian sheep industry more than $780 million annually. Difficult lambing is the leading cause of lamb mortality and weak uterine contractions are the most important contributor to difficult labour (dystocia). Intended outcomes ....Understanding uterine contractility for reducing newborn lamb mortality. The project aims to elucidate the mechanisms underlying normal and dysfunctional uterine contractions in labouring ewes. Significantly, ~20% of newborn lambs die within days of birth, costing the Australian sheep industry more than $780 million annually. Difficult lambing is the leading cause of lamb mortality and weak uterine contractions are the most important contributor to difficult labour (dystocia). Intended outcomes include a better understanding of dysfunctional labour contractions in sheep, and this knowledge could then contribute to the identification of more specific targets for genetic testing for dystocia. The benefits should include more specific aids for selective breeding programs for improved productivity and profitability.Read moreRead less
Antitumour Efficacy Of TRAIL: An Immunotherapeutic Approach For The Treatment Of Skeletal Malignancies
Funder
National Health and Medical Research Council
Funding Amount
$459,034.00
Summary
The most serious clinical problem with patients with solid tumours is metastasis to bone, which leads to complications that can cause erosion of the patient's quality of life, and eventually death. TRAIL is a new cancer therapeutic that selectively kills cancer cells while sparing normal cells. The use of TRAIL agonistic antibodies that do not bind OPG and have increased serum half life offers an exciting approach for the treatment of skeletal malignancies that is non toxic and safe.
The Effect Of Metals On Neurofibrillary Tangle Formation
Funder
National Health and Medical Research Council
Funding Amount
$333,313.00
Summary
The majority of studies into Alzheimer's disease (AD) have focussed on two brain lesions- the plaque and neurofibrillary tangle (NFT), which are believed to have a causative role in AD. Our lab has made several seminal discoveries about the role that metals play in the development of plaques. We are now extending this work to evaluate the role of metals in NFT formation. These studies will provide insight into the formation and possible treatments for this primary brain lesion in AD.